In Zak J. et al.’s study on JAK1-/- and JAK2-/- MC38 tumor-bearing B6 mice, monocytes showed significantly higher levels of MHC-II transcript and protein in tumors treated with dual ICI + JAKi compared to those treated with dual ICI alone. This evidence concerns the gene JAK1 and neoplasm.